All News

2058 articles, sorted by publication time.

Gene Therapy · us

BB-301 Gene Therapy Shows Signs of Improved Swallowing, with Nine Oculopharyngeal Muscular Dystrophy Patients Meeting Response Criteria

A single local administration aims to improve progressively declining swallowing function. All nine patients in an early BB-301 trial met company-defined response criteria, but only three received the high dose, and there was no control group. Efficacy and durability still require confirmation in larger studies.

Clinical Trials · asia

CLDN18.2 Antibody–Drug Conjugate Extends Survival in Advanced Gastric Cancer, Meets Dual Endpoints in Phase 3 Trial

In selected patients with gastric cancer who had received multiple lines of treatment, arcotatug tavatecan extended median overall survival from 6.9 to 10.2 months. The results support a marketing application in Japan, but nearly half of patients receiving the drug experienced grade 3 or higher treatment-related adverse events.

Cancer and Immunotherapy · global

BioNTech Terminates Colorectal Cancer mRNA Vaccine Trial: Imbalance in Survival Data, No New Safety Signals

Using personalized vaccines after surgery to prevent cancer recurrence continues to face clinical challenges. BioNTech has terminated a Phase 2 study after the monitoring committee concluded that continuing the trial was unlikely to change the efficacy outcome. The magnitude and causes of the survival difference, however, await clarification from the full data.